CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Japan Tissue Engineering Company Limited Company Snapshot
Japan Tissue Engineering Company Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Japan Tissue Engineering Company Limited with three other companies in this sector in Japan: Trans Genic Inc (2017 sales of 2.30 billion Japanese Yen [US$20.75 million] of which 50% was CRO Business), PhoenixBio Co Ltd (1.23 billion Japanese Yen [US$11.07 million] ), and Gene Techno Science Co Ltd (1.09 billion Japanese Yen [US$9.82 million] ).

Sales Analysis. Japan Tissue Engineering Company Limited reported sales of ¥2.14 billion (US$19.24 million) for the fiscal year ending March of 2017. This represents an increase of 49.2% versus 2016, when the company's sales were ¥1.43 billion. Sales at Japan Tissue Engineering Company Limited have increased during each of the previous five years (and since 2012, sales have increased a total of 351%). Sales of Regenerative Medicine Products Business saw an increase of 52.8% in 2017, from ¥1.34 billion to ¥2.04 billion. Not all segments of Japan Tissue Engineering Company Limited experienced an increase in sales in 2017: sales of Research and Development Support fell 1.4% to ¥91.82 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Japan Tissue Engineering Company Limited
  Stock Performance Chart for Japan Tissue Engineering Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/15/2017): 1,146.00
(Figures in Japanese Yen)
1 Week 2.3%   13 Weeks -0.7%  
4 Weeks -6.9%   52 Weeks -9.8%  
 
Japan Tissue Engineering Company Limited Key Data:
  Ticker: 7774 Country: Japan
  Exchanges: TYO VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,135,149,000
(Year Ending Jan 2018).
Employees: 174
  Currency: Japanese Yen Market Cap: 46,539,101,256
  Fiscal Yr Ends: March Shares Outstanding: 40,610,036
  Share Type: Common Closely Held Shares: 26,318,400
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.